深圳信立泰药业股份有限公司 关于举行2024年年度业绩说明会 的公告

Core Viewpoint - Shenzhen Xinlitai Pharmaceutical Co., Ltd. is holding an annual performance briefing for the year 2024 to enhance communication with investors and gather their opinions and suggestions [1]. Group 1: Meeting Details - The annual performance briefing will take place on April 10, 2025, from 15:00 to 17:00 via "Value Online" [1]. - Investors can participate in the online briefing through a specific URL or by scanning a QR code [2]. - Key personnel attending the meeting include the General Manager Mr. Yan Jie, Independent Director Mr. Wang Xuegong, Financial Officer Ms. Kong Yun, and Secretary of the Board Mr. Yang Jianfeng [3]. Group 2: Investor Engagement - The company is collecting questions from investors prior to the meeting to enhance the relevance of the discussion [4]. - Investors can submit their questions through the provided URL or by scanning the QR code before April 10, 2025 [4]. - The company aims to address commonly asked questions during the performance briefing within the limits of information disclosure [4].